Cagrilintide is a long-acting amylin analogue being investigated for its potential effects on appetite regulation, food intake and body weight.

Research has explored cagrilintide in relation to:

* Appetite and satiety
* Reduced food intake
* Body-weight management
* Metabolic health
* Combination approaches with GLP-1–based therapies